Algocyte® Achieves CE Certification As A Medical Device

We are very excited to share the announcement that we have accomplished a major milestone in getting Algocyte® certified under the European Commission medical device directive. Algocyte® is OIA’s flagship product, an end-to-end app, and solution for remote blood testing and health monitoring based on our proprietary technology (two patents pending no. 1918950.5 and 1918948.9 (UK)).